Market Cap : 7.59 B | Enterprise Value : 6.53 B | PE Ratio : | PB Ratio : 8.94 |
---|
NAS:IONS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IONS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Ionis Pharmaceuticals's enterprise value is $6,534.0 Mil. Ionis Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was $729.3 Mil. Therefore, Ionis Pharmaceuticals's EV-to-Revenue for today is 8.96.
During the past 13 years, the highest EV-to-Revenue of Ionis Pharmaceuticals was 43.40. The lowest was 3.70. And the median was 10.85.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2021-03-03), Ionis Pharmaceuticals's stock price is $53.420000. Ionis Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $5.22. Therefore, Ionis Pharmaceuticals's PS Ratio for today is 10.23.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Ionis Pharmaceuticals's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Ionis Pharmaceuticals's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 6534.038 | / | 729.264 | |
= | 8.96 |
Ionis Pharmaceuticals's current Enterprise Value is $6,534.0 Mil.
Ionis Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was 133.367 (Mar. 2020 ) + 145.537 (Jun. 2020 ) + 160.079 (Sep. 2020 ) + 290.281 (Dec. 2020 ) = $729.3 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Ionis Pharmaceuticals's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 53.420000 | / | 5.221 | |
= | 10.23 |
Ionis Pharmaceuticals's share price for today is $53.420000.
Ionis Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was 0.957 (Mar. 2020 ) + 1.044 (Jun. 2020 ) + 1.146 (Sep. 2020 ) + 2.074 (Dec. 2020 ) = $5.22.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline